Sex differences in pulmonary (arterial) hypertension: does it matter?
- PMID: 40767089
- PMCID: PMC12331139
- DOI: 10.1097/MCP.0000000000001197
Sex differences in pulmonary (arterial) hypertension: does it matter?
Abstract
Purpose of review: This review synthesizes the current prevailing theories behind the 'sex paradox' or 'sex puzzle' in pulmonary arterial hypertension (PAH), a disease marked by sexual dimorphism. To a lesser extent, we also review sex differences in other forms of pulmonary hypertension.
Recent findings: Although more females than males develop PAH worldwide, female sex is associated with improved right ventricular (RV) function and survival. We review the role of sex chromosomes and sex hormones and their relationships to genomic and epigenetic regulation, immune function, and RV function, sex-based differences in therapeutic response and social determinants of health and intersectionality with gender in PAH pathobiology, prevalence and outcomes. We include experimental studies and observational human data that have led to the study of sex hormone modulation as a treatment strategy in PAH, with recently completed clinical trials. In addition, we explore potential future directions to help understand the mechanisms that underpin sex biases in pulmonary vascular disease, as well as those that may inform potential therapeutic targets.
Summary: Survival in PAH depends on RV function, and females have improved survival despite increased prevalence for reasons that remain unclear. While knowledge gaps remain, recent advancements offer promise and many future directions.
Keywords: pulmonary arterial hypertension; right ventricle; sex chromosomes; sex differences in pulmonary arterial hypertension; sex hormones.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Current landscape for connective tissue disease associated-pulmonary arterial hypertension: a focus on right ventricular adaptation and failure.Future Cardiol. 2025 Aug;21(10):803-814. doi: 10.1080/14796678.2025.2529696. Epub 2025 Jul 11. Future Cardiol. 2025. PMID: 40641351 Review.
-
Pulmonary arterial hypertension: Sex matters.Br J Pharmacol. 2024 Apr;181(7):938-966. doi: 10.1111/bph.16277. Epub 2024 Jan 16. Br J Pharmacol. 2024. PMID: 37939796 Review.
-
Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H351-H363. doi: 10.1152/ajpheart.00098.2024. Epub 2024 Jun 7. Am J Physiol Heart Circ Physiol. 2024. PMID: 38847755 Free PMC article.
-
Pulmonary arterial hypertension: sex-specific differences and outcomes.Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251350493. doi: 10.1177/17534666251350493. Epub 2025 Jun 20. Ther Adv Respir Dis. 2025. PMID: 40539543 Free PMC article. Review.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
References
-
- Shapiro S, Traiger GL, Turner M, et al. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Chest. 2012. Feb;141(2):363–73. - PubMed
-
-
DesJardin JT, Kime N, Kolaitis NA, et al. Investigating the "sex paradox" in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR). J Heart Lung Transplant. 2024;43(6):901–910.
Sex-based analysis of the Pulmonary Hypertension Association Registry. Despite less favorable hemodynamic and metrics, females had a 48% lower risk of death compared to males. After adjustments for covariates, authors raise the possibility of collider-stratification bias or another unmeasured factor to account for the observed increased mortality risk among males with PAH.
-
-
- Hoeper MM, Huscher D, Ghofrani HA, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry. Int J Cardiol. 2013. Sep 30;168(2):871–80. - PubMed
-
-
Pagnesi M, Riccardi M, Savonitto G, et al. Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry. Int J Cardiol. 2025. Jul 1;430:133180.
Real-world registry from seven European PH centers (six in Italy, one in the UK) spanning two-decades with ~66% of patients female. Female sex was independently associated with a lower risk mortality compared with male sex.
-
-
-
Shelburne NJ, Nian H, Beck GJ, et al. Male Sex Is Associated With Worse Right Ventricular Function and Survival in Pulmonary Hypertension in the Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics Cohort. CHEST Pulm. 2024. Sep;100046.
PVDOMICs study in the US across seven PH centers. Patients with PAH and PH were enrolled and underwent hemodynamics, cardiac MRI, and echocardiography to further evaluate the relationship between sex and pulmonary vascular resistance (PVR) and RV ejection fraction. Male sex was associated with worse RV function, decreased transplant-free survival, and elevation in PVR.
-
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials